ImprimePGG

1 stories · following the connections

Business

Biothera Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Study Evaluating Combination of Imprime PGG and Merck’s KEYTRUDA in Non-Small Cell Lung Cancer

By Nasdaq OMXJul 19, 2017, 2:00 PM UTC